Clinical Trials in Pennsylvania

Showing 4241-4260 of 19,675 trials

Testing the Effect of ENDS Flavors on Neurotransmission

NCT05836051

The overarching goal of this translational proposal is to determine if neuroactive flavor chemicals can enhance the addiction potential of electronic nicotine delivery systems (ENDS) by altering brain function and behavior.

Tobacco Dependence

Milton S. Hershey Medical Center36 participantsStarted Jun 2023

Hershey, Pennsylvania, United States

COMPLETEDPhase 340 miles

Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

NCT03367572

This randomized phase III trial studies how well netupitant/palonosetron hydrochloride and dexamethasone with prochlorperazine or olanzapine work compared to netupitant/palonosetron hydrochloride and dexamethasone in improving chemotherapy-induced nausea and vomiting in patients with breast cancer. Antiemetic drugs, such as prochlorperazine and olanzapine, may help lessen nausea and vomiting in patients with breast cancer treated with chemotherapy.

Breast Carcinoma

University of Rochester NCORP Research Base1,363 participantsStarted Apr 2018

Honolulu, Hawaii, United States • Decatur, Illinois, United States • New Orleans, Louisiana, United States +15 more locations

Testing the Effect of ENDS Flavors on Neurotransmission

Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

Find Trials by Condition in Pennsylvania

A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments

Financial Difficulty in Patients With Blood Cancer

A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation With an Open-Label Expansion

First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)

ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

Anti-viral Therapy in Alzheimer's Disease

Single-Sided Deafness and Asymmetric Hearing Loss

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis